Glenmark Generics receives final ANDA approval for Telmisartan tablets
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited...
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited...
Obese patients who underwent surgery or took medications to lose weight were more satisfied with their results than those who...
Since the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly. ...
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to...
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists Lyon, France,...
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to...
Britons can now get a quick HIV test — in 60 seconds flat, when they visit a supermarket. A British...
The takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In...
Par Pharmaceutical Companies, Inc. today issued the following statement in response to inquiries it has received regarding the potential use...
Pfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.